Clinical Trial Update: Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD) [Phase 1]

View source ↗

Summary

Phase 1 study update for AdGVPEDF.11D in neovascular age-related macular degeneration; the GenVec-sponsored trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• AdGVPEDF.11D

Snippet

Sponsor: GenVec | Conditions: Macular Degeneration | Phase 1 | Status: COMPLETED